Literature DB >> 30976087

Microbes, metabolites, and the gut-lung axis.

Anh Thu Dang1, Benjamin J Marsland2.   

Abstract

The microbiota plays an essential role in the education, development, and function of the immune system, both locally and systemically. Emerging experimental and epidemiological evidence highlights a crucial cross-talk between the intestinal microbiota and the lungs, termed the 'gut-lung axis'. Changes in the constituents of the gut microbiome, through either diet, disease or medical interventions (such as antibiotics) is linked with altered immune responses and homeostasis in the airways. The importance of the gut-lung axis has become more evident following the identification of several gut microbe-derived components and metabolites, such as short-chain fatty acids (SCFAs), as key mediators for setting the tone of the immune system. Recent studies have supported a role for SCFAs in influencing hematopoietic precursors in the bone marrow-a major site of innate and adaptive immune cell development. Here, we review the current understanding of host-microbe cross-talk along the gut-lung axis. We highlight the importance of SCFAs in shaping and promoting bone marrow hematopoiesis to resolve airway inflammation and to support a healthy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30976087     DOI: 10.1038/s41385-019-0160-6

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  133 in total

1.  Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.

Authors:  Mairi C Noverr; Nicole R Falkowski; Rod A McDonald; Andrew N McKenzie; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Shifting the balance: antibiotic effects on host-microbiota mutualism.

Authors:  Benjamin P Willing; Shannon L Russell; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2011-02-28       Impact factor: 60.633

Review 3.  Homeostatic Immunity and the Microbiota.

Authors:  Yasmine Belkaid; Oliver J Harrison
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

Review 4.  Effects of gut microbes on nutrient absorption and energy regulation.

Authors:  Rosa Krajmalnik-Brown; Zehra-Esra Ilhan; Dae-Wook Kang; John K DiBaise
Journal:  Nutr Clin Pract       Date:  2012-02-24       Impact factor: 3.080

Review 5.  The germfree animal in nutritional studies.

Authors:  B S Wostmann
Journal:  Annu Rev Nutr       Date:  1981       Impact factor: 11.848

Review 6.  Gut microbiota, metabolites and host immunity.

Authors:  Michelle G Rooks; Wendy S Garrett
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 7.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

Review 8.  How colonization by microbiota in early life shapes the immune system.

Authors:  Thomas Gensollen; Shankar S Iyer; Dennis L Kasper; Richard S Blumberg
Journal:  Science       Date:  2016-04-29       Impact factor: 47.728

9.  Disturbed intestinal integrity in patients with COPD: effects of activities of daily living.

Authors:  Erica P A Rutten; Kaatje Lenaerts; Wim A Buurman; Emiel F M Wouters
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

Review 10.  Diet and microbiota in inflammatory bowel disease: The gut in disharmony.

Authors:  Davy C M Rapozo; Claudio Bernardazzi; Heitor Siffert Pereira de Souza
Journal:  World J Gastroenterol       Date:  2017-03-28       Impact factor: 5.742

View more
  154 in total

Review 1.  Microbial interactions in the atopic march.

Authors:  B Nibbering; N D J Ubags
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

Review 2.  The use of fecal microbiota transplant in sepsis.

Authors:  Robert Keskey; Jennifer T Cone; Jennifer R DeFazio; John C Alverdy
Journal:  Transl Res       Date:  2020-07-07       Impact factor: 7.012

Review 3.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

Review 4.  Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease.

Authors:  An Zhou; Yuanyuan Lei; Li Tang; Shiping Hu; Min Yang; Lingyi Wu; Shiming Yang; Bo Tang
Journal:  J Bacteriol       Date:  2021-01-25       Impact factor: 3.490

Review 5.  The impact of lung microbiota dysbiosis on inflammation.

Authors:  Daping Yang; Yingying Xing; Xinyang Song; Youcun Qian
Journal:  Immunology       Date:  2019-11-11       Impact factor: 7.397

6.  Immunity improvement and gut microbiota remodeling of mice by wheat germ globulin.

Authors:  Guanghai Yu; Xiaoguo Ji; Jihong Huang; Aimei Liao; Long Pan; Yinchen Hou; Ming Hui; Weiyun Guo
Journal:  World J Microbiol Biotechnol       Date:  2021-03-18       Impact factor: 3.312

7.  Microbial metabolism of L-tyrosine protects against allergic airway inflammation.

Authors:  Tomasz P Wypych; Céline Pattaroni; Olaf Perdijk; Carmen Yap; Aurélien Trompette; Dovile Anderson; Darren J Creek; Nicola L Harris; Benjamin J Marsland
Journal:  Nat Immunol       Date:  2021-01-25       Impact factor: 25.606

Review 8.  ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.

Authors:  Ravindra K Sharma; Bruce R Stevens; Alexander G Obukhov; Maria B Grant; Gavin Y Oudit; Qiuhong Li; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Hypertension       Date:  2020-08-12       Impact factor: 10.190

Review 9.  Host responses to mucosal biofilms in the lung and gut.

Authors:  Jada C Domingue; Julia L Drewes; Christian A Merlo; Franck Housseau; Cynthia L Sears
Journal:  Mucosal Immunol       Date:  2020-02-28       Impact factor: 7.313

Review 10.  Immunomodulation by radiotherapy in tumour control and normal tissue toxicity.

Authors:  Urszula M Cytlak; Douglas P Dyer; Jamie Honeychurch; Kaye J Williams; Mark A Travis; Timothy M Illidge
Journal:  Nat Rev Immunol       Date:  2021-07-01       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.